Inebilizumab-cdon is approved for anti-acetylcholine receptor and anti-muscle specific tyrosine kinase antibody–positive generalized myasthenia gravis, based on MINT trial results. Inebilizumab gains ...

SAVANNAH, Ga. — Should patients with myasthenia gravis (MG) continue to undergo the traditional therapy of immunosuppression with drugs like corticosteroids and nonsteroidal agents? Or is it time to ...

Myasthenia gravis is a chronic and often debilitating autoimmune disease characterized by muscle weakness. A key underlying mechanism is the production of autoantibodies by plasma cells — but current ...

Drooping eyelids, referred to as ptosis, are a common symptom of myasthenia gravis. The disease can weaken muscles around the eye, as well as muscles involved with walking, breathing, and more.

Positive topline results from two phase 3 trials reported this week may expand the treatment landscape for generalized myasthenia gravis (gMG), a rare autoimmune disease marked by debilitating muscle ...

The first study to use an RNA-based chimeric antigen receptor T-cell (rCAR-T) therapy in autoimmune disease showed people with generalized myasthenia gravis tolerated the treatment well and ...

The therapy is already being evaluated in patients with lupus nephritis and diffuse cutaneous systemic sclerosis. "We have seen firsthand the transformative effects of KYV-101 in MG patients treated ...

Myasthenia gravis is a chronic autoimmune disorder that inhibits communication between nerve cells and muscles, causing muscle weakness. It has no cure, but several treatment options can help improve ...

AstraZeneca (NASDAQ:AZN) announced Thursday that gefurulimab, its experimental injectable for generalized myasthenia gravis, reached the main goals in a Phase 3 trial for the rare autoimmune disorder.

SAN FRANCISCO -- Descartes-08, an autologous, B-cell maturation antigen (BCMA)-directed mRNA chimeric antigen receptor (CAR) T-cell therapy, led to sustained responses in generalized myasthenia gravis ...

MYASTHENIA gravis is an uncommon disorder of unknown cause. Current evidence suggests that it may be related to abnormal immune mechanisms because of its frequent association with more clearly defined ...